Show simple item record

Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells

dc.contributor.authorLucas, Rudolfen_US
dc.contributor.authorGarcia, Ireneen_US
dc.contributor.authorDonati, Yves R. A.en_US
dc.contributor.authorHribar, Marusaen_US
dc.contributor.authorMandriota, Stefano J.en_US
dc.contributor.authorGiroud, Christineen_US
dc.contributor.authorBuurman, Wim A.en_US
dc.contributor.authorFransen, Lucieen_US
dc.contributor.authorSuter, Peter M.en_US
dc.contributor.authorNuñez, Gabrielen_US
dc.contributor.authorPepper, Michael S.en_US
dc.contributor.authorGrau, Georges E.en_US
dc.date.accessioned2006-09-20T15:03:29Z
dc.date.available2006-09-20T15:03:29Z
dc.date.issued1998-11en_US
dc.identifier.citationLucas, Rudolf; Garcia, Irene; Donati, Yves R. A.; Hribar, Marusa; Mandriota, Stefano J.; Giroud, Christine; Buurman, Wim A.; Fransen, Lucie; Suter, Peter M.; NuÑez, Gabriel; Pepper, Michael S.; Grau, Georges E. (1998)."Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells." European Journal of Immunology 28(11): 3577-3586. <http://hdl.handle.net/2027.42/48707>en_US
dc.identifier.issn0014-2980en_US
dc.identifier.issn1521-4141en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/48707
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=9842900&dopt=citationen_US
dc.description.abstractThe conditions under which tumor necrosis factor-α (TNF) induces apoptosis in primary microvascular endothelial cells (MVEC) were investigated. In the absence of sensitizing agents, TNF induced apoptosis after 3 days of incubation in confluent MVEC. In contrast, upon addition of the transcriptional inhibitor actinomycin D (Act. D), confluence was no longer required and apoptosis occurred already after 16 h. To assess the role of either TNF receptor (TNFR) type in apoptosis, MVEC isolated from mice genetically deficient in TNFR1 (  Tnfr1  ° mice) or TNFR2 (  Tnfr2  ° mice) were incubated with TNF in the presence or absence of Act. D. Under sensitized conditions, Tnfr2  ° MVEC were lysed like controls, whereas Tnfr1  ° MVEC were completely resistant, indicating an exclusive role for TNFR1. In contrast, in the absence of Act. D, confluent monolayers of wild-type cells were lysed by TNF, but both Tnfr1  ° and Tnfr2  ° MVEC were resistant to TNF-mediated toxicity, indicating a requirement for both TNFR types. Overexpression of the anti-apoptotic protein bcl-xL in MVEC led to a protection against the direct, but not the sensitized cytotoxicity of TNF. In conclusion, in pathophysiologically relevant conditions, both TNFR appear to be required for TNF-induced apoptosis in MVEC.en_US
dc.format.extent154676 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherWILEY-VCH Verlag GmbHen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherMicrobiology and Immunologyen_US
dc.titleBoth TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cellsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arbor, USAen_US
dc.contributor.affiliationotherLaboratory of Immunopathology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Geneva, Switzerland ; Laboratory of Intensive Care, Department of Internal Medicine, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherDepartment of Pathology, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherLaboratory of Immunopathology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherLaboratory of Intensive Care, Department of Internal Medicine, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherDepartment of Morphology, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherLaboratory of Immunopathology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherDepartment of Surgery, University of Limburg, Maastricht, The Netherlandsen_US
dc.contributor.affiliationotherInnogenetics, Ghent, Belgiumen_US
dc.contributor.affiliationotherLaboratory of Immunopathology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherDepartment of Morphology, University Medical Center, University of Geneva, Geneva, Switzerlanden_US
dc.contributor.affiliationotherLaboratory of Immunopathology, Department of Anaesthesiology, Pharmacology and Surgical Intensive Care, University Medical Center, University of Geneva, Geneva, Switzerland ; CNRS – UPRES A6020, Faculty of Medicine, UniversitÉ de la MÉditerranÉe, Marseille, Franceen_US
dc.identifier.pmid9842900en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/48707/1/3577_ftp.pdfen_US
dc.identifier.doi10.1002/(ISSN)1521-4141
dc.identifier.sourceEuropean Journal of Immunologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.